StockNews.com Begins Coverage on Sorrento Therapeutics (NASDAQ:SRNE)
Investment analysts at StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research report issued to clients and investors on Sunday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Stock Performance Sorrento Therapeutics stock opened at $0.00 on Friday. Sorrento Therapeutics has a 52-week […]
More Stories
Florence Pugh: Net Worth, Salary, and Relationship with Finn Cole
British movies, blockbusters, and even Marvel movies have enabled Florence Pugh to have a strong career in Hollywood. She is...
Macron Affirms Support for Greenland Sovereignty Amid US Interest in Annexation
By Rachel Roberts French President Emmanuel Macron has reaffirmed his support for the sovereignty of the Danish territory of Greenland...
DOJ Releases More Epstein Files, Says Some Documents Contain False Claims
By Jack Phillips The Department of Justice (DOJ) on Tuesday morning released thousands of documents related to the now-deceased convicted...
House Oversight Committee Expands Investigation Into Minnesota Fraud
By Jackson Richman The House Oversight Committee expanded its investigation into fraud in Minnesota on Dec. 22. The committee has...
US Economy Expands 4.3 Percent in 3rd Quarter, Topping Expectations
By Andrew Moran Robust consumer spending and a rebound in exports have helped the U.S. economy grow faster than economists...
Is A Man on the Inside Season 3 Confirmed? Everything We Know So Far
Upon the completion of Season 2 of the series A Man on the Inside, people started asking for the series’...